Documenting medication errors with an incident/medication error report is the standard method to promote safety and drive improvements after an event. This form captures key details such as what happened, when and where it occurred, the medications involved, dosages, and patient information, along with who was involved. It also records suspected contributing factors, immediate actions taken, and recommended corrective actions. Building this structured record enables root-cause analysis, trend monitoring, and changes to procedures or policies to prevent recurrence, often within a system that supports reporting and learning while protecting confidentiality. Other terms don’t fit as well because they either lack the formal structure for comprehensive data collection or focus on tracking system activity rather than guiding safety improvements.

The NDC identifies the drug product by three parts: the manufacturer (labeler), the specific product (drug, strength, dosage form), and the package size or type. This standardized code uniquely labels each product and its packaging, aiding pharmacists, insurers, and suppliers in dispensing the exact item and processing accurate billing and recalls. It does not convey information about the patient, drug interactions, side effects, or contraindications. It also isn’t about dispensing date, lot numbers, or storage conditions. So the option listing manufacturer, product, and package size matches what the NDC identifies.

In iPLEDGE, every isotretinoin prescription must be documented with both the authorization details and the timing information, and then updated in the system. The RMA number is the unique authorization tied to the patient’s prescription, while the dispense-by date indicates the last day the medication can be dispensed for that cycle. Recording both on the prescription and re-scanning ensures the dispensing record is complete and accurately reflected in the iPLEDGE database, supporting compliance checks and patient safety. The patient’s phone number isn’t part of this required documentation.

When Warfarin is in use, the blood doesn’t clot as easily, and NSAIDs can worsen that bleeding risk. NSAIDs interfere with platelet function and can irritate the stomach lining, so combining them with Warfarin can lead to more bleeding events than either drug alone. Because of this, it’s important to warn the patient that taking NSAIDs can raise the chance of bleeding and to notify the pharmacist about the NSAID use. The patient should report any signs of bleeding right away, such as unusual bruising, prolonged bleeding from cuts, bleeding gums or nosebleeds, heavier menstrual bleeding, black or tarry stools, red or dark urine, or vomiting blood. If pain relief is needed, consider alternatives and avoid NSAIDs unless advised by a clinician, and never adjust Warfarin dose without medical guidance.